Ken Yamazumi
Director/Board Member at SanBio, Inc.
Profile
Ken Yamazumi is currently the Director & External Auditor at SanBio, Inc. He was previously the Chairman & President at Kirin Pharma Co. Ltd.
from 2007 to 2008, and the Representative Director & Executive Vice President at Kyowa Kirin Co., Ltd.
from 2011 to 2012.
Mr. Yamazumi received his undergraduate degree from the University of Tokyo in 1973.
Ken Yamazumi active positions
| Companies | Position | Start |
|---|---|---|
SanBio, Inc.
 SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Director/Board Member | - |
Former positions of Ken Yamazumi
| Companies | Position | End |
|---|---|---|
| KYOWA KIRIN CO. LTD. | Director/Board Member | 2012-03-21 |
Kirin Pharma Co. Ltd.
 Kirin Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Kirin Pharma Co. Ltd. manufactures and sells pharmaceutical products. Its products include Nesp, Regpara Tablets, Espo, Phosblock and Gran. The company was founded in 2007 and is headquartered in Tokyo, Japan | Chairman | 2008-10-05 |
Training of Ken Yamazumi
| University of Tokyo | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| KYOWA KIRIN CO. LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Kirin Pharma Co. Ltd.
Kirin Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Kirin Pharma Co. Ltd. manufactures and sells pharmaceutical products. Its products include Nesp, Regpara Tablets, Espo, Phosblock and Gran. The company was founded in 2007 and is headquartered in Tokyo, Japan | Health Technology |
SanBio, Inc.
SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Health Services |
- Stock Market
- Insiders
- Ken Yamazumi